A Trusted Data Source for Supply & Demand Side Intelligence

Forgot your login?

Enter the e-mail address you used when you registered an account with IIR Energy.

A message will be sent to the E-Mail Address found in our records containing the associated username(s) as well as instructions for a password reset.

E-Mail:
Also, what is 30 + 1?

No Wrinkles in Actavis' $66 Billion Deal to Buy Botox Maker Allergan

No Wrinkles in Actavis

SUGAR LAND--December 3, 2014--Reported by Annette Kreuger for Industrial Info Resources (Sugar Land, Texas)--Pharmaceutical company Allergan (NYSE:AGN) (Irvine, California) has accepted a $66 billion buyout offer from Actavis (NYSE:ACT) (Dublin, Ireland), following months of pursuit by Valeant Pharmaceuticals (NYSE:VRX) (Laval, Quebec). Allergan, known chiefly for wrinkle reducer Botox, had continually spurned Valeant's offers, which had reached a peak of $53 billion last May.

Within this article: Details on the buyout, including a list of plants tracked by Industrial Info.

Login or Register for Instant Access

Subscribe Now!

(All Fields Required)